Annette Langer-Gould, MD, PhD
Southern California Permanente Medical Group/Kaiser Permanente
Annette Langer-Gould, MD, PhD, is the regional lead for translational neuroscience for the Southern California Permanente Medical Group and internationally recognized expert in multiple sclerosis research. She completed her residency, PhD in epidemiology and post-doctoral fellowship at Stanford University and developed expertise in specialty pharmaceuticals and drug development as assistant medical director at Roche/Genentech. She has been studying different epidemiological aspects of MS susceptibility and prognosis for over 20 years including race and ethnicity, vitamin D, sun exposure, genotype, pregnancy, breastfeeding, the comparative effectiveness of rituximab and other MS treatments. Most recently—through an NIH-funded award—the complex interplay between social determinants of health and racial and ethnic disparities in MS outcomes. Her collaborators include investigators in Sweden, Australia, Germany and multiple academic institutions in the US. She has received grant support and awards from the National Institutes of Health, Patient Centered Outcomes Research Institute, and the National MS Society.